← Leaderboards
Nina F Schor
Children'S Hosp Pittsburgh/Upmc Hlth Sys
$9,201,297
Attributed
$9,201,297
Total exposure
7
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.1M · FY2005–15$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$9,201,297 · 7
By mechanism
R01$5,192,434 · 3
K12$1,998,000 · 1
T32$1,936,122 · 2
T35$74,741 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Apoptosis”
- David Heimbrook · Leidos Biomedical Research, Inc.$49,205,802
- Jay A Nelson · Oregon Health & Science University$45,942,124
- John C Reed · University Of Texas Md Anderson Can Ctr$34,437,189
- John A Tainer · Scripps Research Institute$30,637,655
- Henry Shelton Earp · Univ Of North Carolina Chapel Hill$28,872,594
- John D Minna · University Of Texas Sw Med Ctr/Dallas$27,317,167
Research focus
ApoptosisAthymic MouseNeoplasm /Cancer PharmacologyDrug ResistanceTissue /Cell CulturePc12 CellsPediatric ResearchNuclear Factor Kappa BetaNerve Growth FactorsNeuroblastomaLaboratory MouseDrug Design /Synthesis /ProductionEnvironmentFundingResearch PersonnelChildhoodMonoclonal AntibodyNeoplasm /Cancer TransplantationDrug Screening /EvaluationBcl2 Gene /ProteinNeoplastic GrowthCell LineNeoplasm /Cancer ChemotherapyCarcinogenesis Inhibitor
Grant awards (39)
Translational Molecular Pediatric Research$432,000
K12 · FY2015 · HD · contact PI
Translational Molecular Pediatric Research$432,000
K12 · FY2014 · HD · contact PI
Pediatric Research: Bench to Bedside to Curbside$253,225
T32 · FY2014 · HD · contact PI
Translational Molecular Pediatric Research$432,000
K12 · FY2013 · HD · contact PI
Pediatric Research: Bench to Bedside to Curbside$242,468
T32 · FY2013 · HD · contact PI
Translational Molecular Pediatric Research$351,000
K12 · FY2012 · HD · contact PI
Pediatric Research: Bench to Bedside to Curbside$240,981
T32 · FY2012 · HD · contact PI
Translational Molecular Pediatric Research$351,000
K12 · FY2011 · HD · contact PI
Pediatric Research: Bench to Bedside to Curbside$242,965
T32 · FY2011 · HD · contact PI
Pediatric Research: Bench to Bedside to Curbside$117,310
T32 · FY2010 · HD · contact PI
Neurotrophic Mechanisms in Neuroblastoma$311,861
R01 · FY2008 · NS · contact PI
Neurotrophic Mechanisms in Neuroblastoma$312,951
R01 · FY2007 · NS · contact PI
Targeted Therapy for Chemoresistant Tumors$193,151
R01 · FY2006 · CA · contact PI
Neurotrophic Mechanisms in Neuroblastoma$152,248
R01 · FY2006 · NS · contact PI
Neurotrophic Mechanisms in Neuroblastoma$124,647
R01 · FY2006 · NS · contact PI
Targeted Therapy for Chemoresistant Tumors$62,676
R01 · FY2006 · CA · contact PI
Neurotrophic Mechanisms in Neuroblastoma$283,559
R01 · FY2005 · NS
Targeted Therapy for Chemoresistant Tumors$261,984
R01 · FY2005 · CA
Childhood Neurodevelopmental and Degenerative Disease$242,230
T32 · FY2005 · NS
Antioxidant Strategies for Parkinson's Disease$231,072
R01 · FY2005 · NS
Antioxidant Strategies for Parkinson's Disease$58,084
R01 · FY2005 · NS
NEURODEVELOPMENTAL AND NEURODEGERENTATIVE DISEASE$31,012
T35 · FY2005 · NS
Neurotrophic Mechanisms in Neuroblastoma$318,533
R01 · FY2004 · NS
Antioxidant Strategies for Parkinson's Disease$289,156
R01 · FY2004 · NS
Targeted Therapy for Chemoresistant Tumors$261,925
R01 · FY2004 · CA
Childhood Neurodevelopmental and Degenerative Disease$242,230
T32 · FY2004 · NS
NEURODEVELOPMENTAL AND NEURODEGERENTATIVE DISEASE$23,778
T35 · FY2004 · NS
Antioxidant Strategies for Parkinson's Disease$288,563
R01 · FY2003 · NS
Targeted Therapy for Chemoresistant Tumors$271,952
R01 · FY2003 · CA
NEUROTROPHIC MECHANISMS IN NEUROBLASTOMA$258,133
R01 · FY2003 · NS
Childhood Neurodevelopmental and Degenerative Disease$240,856
T32 · FY2003 · NS
NEURODEVELOPMENTAL AND NEURODEGERENTATIVE DISEASE$19,951
T35 · FY2003 · NS
Antioxidant Strategies for Parkinson's Disease$293,345
R01 · FY2002 · NS
NEUROTROPHIC MECHANISMS IN NEUROBLASTOMA$232,117
R01 · FY2002 · NS
Childhood Neurodevelopmental and Degenerative Disease$113,857
T32 · FY2002 · NS
TARGETED THERAPY FOR CHEMORESISTANT TUMORS$270,880
R01 · FY2001 · CA
NEUROTROPHIC MECHANISMS IN NEUROBLASTOMA$225,397
R01 · FY2001 · NS
TARGETED THERAPY FOR CHEMORESISTANT TUMORS$261,326
R01 · FY2000 · CA
NEUROTROPHIC MECHANISMS IN NEUROBLASTOMA$228,874
R01 · FY2000 · NS